First Tracks Biotherapeutics Inc <TRAX.O>: UBS raises target price to $65 from $45
TRAX•Related News
Nasdaq trade halt continues <SVA.O> reason not available at 10:10 AM
SVA•
Spyre Therapeutics Announces Launch Of Spy772 Program
SYRE•
Nasdaq Trade Halt <STKH.O> Volatility Trading Pause at 09:47 AM
STKH•
Dana to join J.P. Morgan Auto Conference fireside chat with CEO Byron Foster
DAN•
Duolingo Appoints Sallie Krawcheck To Board of Directors
DUOL•